Frontier Biotechnologies Inc. Class ASSE: 688221

Announcement on Voluntary Disclosure of Acceptance Notice for the Clinical Trial Application for Domestic Production of Drugs of FB7013

· Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Acceptance Notice for the Clinical Trial Application for Domestic Production of Drugs of FB7013

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis